Drug Shortage Report for ZANTAC

Last updated on 2020-02-27 History
Report ID 2761
Drug Identification Number 02212358
Brand name ZANTAC
Common or Proper name Ranitidine tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60's
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-19
Estimated end date
Actual end date 2017-09-14
Shortage status Resolved
Updated date 2020-02-27
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-02-27 French Compare
v20 2020-02-27 English Compare
v19 2017-09-18 French Compare
v18 2017-09-18 English Compare
v17 2017-09-18 French Compare
v16 2017-04-20 French Compare
v15 2017-04-19 French Compare
v14 2017-04-19 English Compare
v13 2017-04-19 English Compare
v12 2017-04-19 English Compare
v11 2017-04-19 English Compare
v10 2017-04-18 English Compare
v9 2017-04-12 French Compare
v8 2017-04-12 English Compare
v7 2017-04-08 English Compare
v6 2017-04-05 French Compare
v5 2017-04-05 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-14 French Compare

Showing 1 to 20 of 21